𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hop: more than an Hsp70/Hsp90 adaptor protein

✍ Scribed by O.O. Odunuga; V.M. Longshaw; G.L. Blatch


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
519 KB
Volume
26
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Molecular chaperones facilitate the correct folding of other proteins under physiological and stress conditions. Recently it has become evident that various co‐chaperone proteins regulate the cellular functions of these chaperones, particularly Hsp70 and Hsp90. Hop is one of the most extensively studied co‐chaperones that is able to directly associate with both Hsp70 and Hsp90. The current dogma proposes that Hop functions primarily as an adaptor that directs Hsp90 to Hsp70‐client protein complexes in the cytoplasm. However, recent evidence suggests that Hop can also modulate the chaperone activities of these Hsps, and that it is not dedicated to Hsp70 and Hsp90. While the co‐chaperone function of Hop within the cytoplasm has been extensively studied, its association with nuclear complexes and prion proteins remains to be elucidated. This article will review the structural features of Hop, and the evidence that its biological function is considerably broader than previously envisaged. BioEssays 26:1058–1068, 2004. © 2004 Wiley Periodicals, Inc.


📜 SIMILAR VOLUMES


PINCH: More than just an adaptor protein
✍ Jane Kovalevich; Brittany Tracy; Dianne Langford 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

## Abstract Particularly __i__nteresting __n__ew __c__ysteine‐__h__istidine‐rich protein (PINCH) is a LIM‐domain‐only adaptor protein involved in protein recruitment, subsequent assembly of multi‐protein complexes, and subcellular localization of these complexes. PINCH is developmentally regulated

Persistence of myeloma protein for more
✍ Richard B. Wilder; Chul S. Ha; James D. Cox; Donna Weber; Kay Delasalle; Raymond 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## BACKGROUND Prognostic factors for solitary plasmacytoma of bone (SPB), whether measured before or after radiotherapy (RT), have not been established. The authors analyzed multiple factors for myeloma‐free survival (MFS) and cause‐specific survival (CSS) in SPB patients treated with